Informed Consent for Laparoscopic Cholecystectomy (Gallbladder Removal)

Section 1info grid
Section 2text block
Section 3text block
Section 4list block
Section 5list block
Section 6text block
Section 7text block
Section 8text block
Section 9text block
Section 10text block
Section 11text block
Section 12text block
Section 13signature block

Informed Consent for Laparoscopic Cholecystectomy (Gallbladder Removal)

Patient and Surgical Information

Nature and Purpose of the Procedure

Laparoscopic cholecystectomy is the standard surgical procedure for removal of the gallbladder, performed under general anesthesia. Four small incisions (5-12 mm) are made in the abdomen. Carbon dioxide gas is insufflated to create a pneumoperitoneum, creating working space within the abdominal cavity. A camera (laparoscope) and specialized surgical instruments are inserted through the ports. The cystic duct and cystic artery are identified, clipped, and divided. The gallbladder is then dissected from the liver bed using electrosurgery and extracted through the umbilical port. The procedure typically takes 45 to 90 minutes and is performed as a same-day or overnight surgery. Intraoperative cholangiography (X-ray of the bile ducts using contrast dye injected through the cystic duct) may be performed to delineate ductal anatomy and detect common bile duct stones. A drain may be placed in the gallbladder fossa at the surgeon's discretion. If safe laparoscopic dissection is not achievable due to severe inflammation, dense adhesions, bleeding, or anatomical confusion, the surgeon will convert to an open cholecystectomy via a right subcostal (Kocher) incision.

Potential for Conversion to Open Surgery

The rate of conversion from laparoscopic to open cholecystectomy is approximately 3 to 5 percent for elective cases and up to 15 to 20 percent for acute cholecystitis or previously operated abdomens. If conversion is required, the open procedure involves a larger incision (15 to 20 cm) under the right ribcage, a longer recovery of 4 to 6 weeks compared to 1 to 2 weeks laparoscopically, and increased risk of wound complications. The decision to convert is always made in the interest of patient safety.

Material Risks and Potential Complications

Common bile duct (CBD) injury: the most serious complication of cholecystectomy, occurring in approximately 0.3 to 0.5 percent of laparoscopic cases. Complete bile duct transaction requires major biliary reconstruction (hepaticojejunostomy) by a hepatobiliary specialist, carries significant morbidity, and may lead to chronic biliary stricture and liver injury.
Bile leak: post-operative bile leakage from the cystic duct stump or a minor ductal injury, occurring in approximately 0.5 to 2 percent. May resolve spontaneously or require ERCP and sphincterotomy with biliary stenting, or surgical re-exploration.
Injury to surrounding structures: inadvertent damage to the right hepatic artery, portal vein, right colon, duodenum, or stomach during dissection, which may require immediate surgical repair.
Retained common bile duct stones: pre-existing CBD stones undetected prior to surgery may cause postoperative jaundice, cholangitis, or pancreatitis, requiring ERCP with stone extraction after surgery.
Port-site hernia: herniation of bowel through a trocar site incision, particularly at the umbilical 12 mm port, occurring in approximately 1 percent. May require subsequent hernia repair.
Pneumoperitoneum-related complications: carbon dioxide insufflation may cause subcutaneous emphysema, pneumothorax, gas embolism, or cardiac arrhythmias in rare cases.
Post-cholecystectomy syndrome: persistent right upper quadrant pain, dyspepsia, diarrhea, or biliary-type pain following gallbladder removal, occurring in 10 to 15 percent of patients. Usually due to motility disorders, sphincter of Oddi dysfunction, or retained CBD stones.
Wound infection, bleeding, or haematoma formation at port sites.

Alternatives to Cholecystectomy

Conservative dietary management: a low-fat diet may reduce the frequency of biliary colic attacks in mild symptomatic gallstone disease, but does not eliminate stones or prevent disease progression, acute cholecystitis, or CBD stone migration.
Ursodeoxycholic acid (UDCA) dissolution therapy: oral bile acid therapy may dissolve small cholesterol gallstones over 6 to 24 months; only suitable for small (less than 5 mm), radiolucent cholesterol stones in a functioning gallbladder; high recurrence rate on cessation; not appropriate for calcified, pigment, or large stones.
Percutaneous cholecystostomy: drainage of the gallbladder via a radiologically placed tube through the skin, used as a temporary measure in critically unwell patients who are unfit for surgery; does not remove the gallbladder.

Postoperative Dietary Guidance

Following cholecystectomy, bile flows continuously from the liver into the small intestine without the regulatory storage function of the gallbladder. Most patients tolerate a normal diet without restriction, but some experience diarrhea or bloating from fat-rich meals, particularly in the first 4 to 6 weeks. A temporary low-fat diet during the early recovery phase is recommended. The majority of patients have no long-term dietary restrictions.

Expected Benefits

The primary expected benefit of laparoscopic cholecystectomy is permanent resolution of symptomatic gallstone disease. Removal of the gallbladder eliminates the source of biliary colic, acute cholecystitis, and gallstone pancreatitis. The vast majority of patients (over 90 percent) experience complete resolution of gallstone symptoms. The minimally invasive laparoscopic approach enables same-day or overnight hospitalization, smaller incisions, reduced postoperative pain, earlier return to normal activities, and lower wound complication rates compared to open cholecystectomy.

Right to Refuse or Withdraw Consent

You have the right to refuse this procedure or withdraw your consent at any time before the procedure begins without penalty or adverse effect on your medical care. Your surgeon will discuss non-surgical management alternatives with you if you choose not to proceed.

Questions and Understanding Confirmation

I confirm that I have had the opportunity to read this consent form and ask questions of my surgeon. I understand the risk of bile duct injury and the surgeon's protocol to minimize it, including intraoperative cholangiography. All my questions have been answered to my satisfaction.

Language Access and Interpreter Services

If English is not your primary language or if you require assistance communicating, a qualified medical interpreter is available at no cost. Please notify your care team before signing this document.

Copy of Consent Acknowledgment

I acknowledge that I have been offered a signed copy of this informed consent form for my own records.

Patient Authorization

I consent to laparoscopic cholecystectomy and authorize the surgeon to convert to open surgery if required for patient safety. I have been informed of the risk of bile duct injury and the steps taken to minimize it, including intraoperative cholangiography. I understand the recovery timeline and dietary adjustments that may be required.

Signatures and Verification

Patient / LAR Signature
Surgeon Signature
Witness Signature
Date and Time
Document ID: CC-PENDING
CONSENTCOLLECT